-
1
-
-
0032550630
-
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease
-
Diam J, Alan W, Kevin M, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease [J]. JAMA, 1998,279:1542-1547.
-
(1998)
JAMA
, vol.279
, pp. 1542-1547
-
-
Diam, J.1
Alan, W.2
Kevin, M.3
-
2
-
-
0033069430
-
Usefulness of free prostate specific antigen in the detection of prostate cancer
-
Azocar G, Castillo O, Van Cauwelaert R, et al. Usefulness of free prostate specific antigen in the detection of prostate cancer [J]. Rev Med Chil, 1999,127(2):151-157.
-
(1999)
Rev Med Chil
, vol.127
, Issue.2
, pp. 151-157
-
-
Azocar, G.1
Castillo, O.2
Van Cauwelaert, R.3
-
3
-
-
0034039983
-
Prostate specific antigen only progression of prostate cancer
-
Moul JW. Prostate specific antigen only progression of prostate cancer [J]. J Urol, 2000,163(6):1632-1642.
-
(2000)
J Urol
, vol.163
, Issue.6
, pp. 1632-1642
-
-
Moul, J.W.1
-
4
-
-
0032790236
-
Prostate - Specific antigen for prostate cancer screening. Do physician characteristics affect its use?
-
Edlefsen KL, Mandelson MT, McIntosh MW, et al. Prostate - specific antigen for prostate cancer screening. Do physician characteristics affect its use? [J]. Am J Prev Med, 1999,17(1):87-90.
-
(1999)
Am J Prev Med
, vol.17
, Issue.1
, pp. 87-90
-
-
Edlefsen, K.L.1
Mandelson, M.T.2
McIntosh, M.W.3
-
5
-
-
0031396615
-
The role of free prostate - Specific antigen in the diagnosis of prostate cancer
-
Akdas A, Cevik I, Tarcan T, et al. The role of free prostate - specific antigen in the diagnosis of prostate cancer [J]. Br J Urol, 1997,79:920-923.
-
(1997)
Br J Urol
, vol.79
, pp. 920-923
-
-
Akdas, A.1
Cevik, I.2
Tarcan, T.3
-
6
-
-
0030854473
-
Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prosatate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10.0 ng/ml
-
Morote J, Raventos CX, Lorente J A, et al. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prosatate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10.0 ng/ml [J]. J Urol, 1997,158:502-504.
-
(1997)
J Urol
, vol.158
, pp. 502-504
-
-
Morote, J.1
Raventos, C.X.2
Lorente, J.A.3
-
7
-
-
0034981586
-
Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0ng/ml
-
Okihara K, Fritsche HA, Ayala A, et al. Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0ng/ml [J]. J Urol, 2001, 165:1930-1936.
-
(2001)
J Urol
, vol.165
, pp. 1930-1936
-
-
Okihara, K.1
Fritsche, H.A.2
Ayala, A.3
-
8
-
-
0035047888
-
Free and complexed prostate - Specific antigen (PSA) in the early detection of prostate cancer
-
Tello FL, Prats CH, Gonzalez MD, et al. Free and complexed prostate - specific antigen (PSA) in the early detection of prostate cancer [J]. Clin Chem Lab Med, 2001,39(2):116-120.
-
(2001)
Clin Chem Lab Med
, vol.39
, Issue.2
, pp. 116-120
-
-
Tello, F.L.1
Prats, C.H.2
Gonzalez, M.D.3
|